Lenire

About Neuromod Devices

Neuromod Devices is a commercial-stage medical device company that has achieved a significant milestone with the FDA approval of its flagship product, Lenire, for tinnitus treatment. The company's core technology is bimodal neuromodulation, which has been validated in three large-scale, peer-reviewed clinical trials involving over 600 patients. Neuromod operates a B2B2C model, distributing Lenire through a network of over 200 clinicians across more than 130 clinics in the US and Europe, supported by a comprehensive partner platform for training and practice enablement. With a strong IP portfolio of 136+ patents across 37 countries, Neuromod is positioned as a category creator in the substantial and underserved tinnitus market.

Therapeutic Areas

Other Tinnitus Drugs